PARIS--(BUSINESS WIRE)--Regulatory News:
CARMAT (Paris:ALCAR) (FR0010907956, ALCAR), the designer and developer of the worlds most advanced total artificial heart project, aiming to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure, today announced that it has received authorization to resume the PIVOTAL study in Kazakhstan.
The implants will be performed at the National Research Center for Cardiac Surgery in Nur-Sultan (formerly called Astana), where the teams, led by Professor Yuri Pya, have successfully implanted the CARMAT device during the first part of the PIVOTAL study. Furthermore, several bridge-to-transplant surgeries conducted in this center demonstrated the ability of its surgical teams to successfully manage the explant procedure of the device as a donor heart becomes available. With authorizations in Kazakhstan, the Czech Republic and Denmark, the Company aims to complete enrollment of the second cohort of patients in the PIVOTAL study in order to obtain CE marking in 2020.
Stphane Piat, Chief Executive Officer of CARMAT, said: We are pleased to announce that we have been given the approval to enroll new patients in Kazakhstan. Together with the teams in Nur-Sultan, we are actively preparing for upcoming implants. With this approval, we reach our objective to resume the study at a center experienced both with device implantation and explant for transplant-eligible patients.
About CARMAT: the worlds most advanced total artificial heart project
A credible response to end-stage heart failure: CARMAT aims to eventually provide a response to a major public health issue associated with heart disease, the worlds leading cause of death: chronic and acute heart failure. By pursuing the development of its total artificial heart, composed of the implantable bioprosthesis and its portable external power supply system to which it is connected, CARMAT intends to overcome the well-known shortfall in heart transplants for the tens of thousands of people suffering from irreversible end-stage heart failure, the most seriously affected of the 20 million patients with this progressive disease in Europe and the United States.
The result of combining two types of unique expertise: the medical expertise of Professor Carpentier, known throughout the world for inventing Carpentier-Edwards heart valves, which are the most used in the world, and the technological expertise of Airbus Group, world aerospace leader.
The first physiological artificial heart: given its size, the use of highly biocompatible materials, its unique self-regulation system and its pulsatile nature, the CARMAT total artificial heart could, assuming the clinical trials are successful, potentially save the lives of thousands of patients each year with no risk of rejection and with a good quality of life.
A project leader acknowledged at a European level: with the backing of the European Commission, CARMAT has been granted the largest subsidy ever given to an SME by Bpifrance; a total of 33 million.
Strongly committed, prestigious founders and shareholders: Matra Dfense SAS (subsidiary of the Airbus Group), Professor Alain Carpentier, the Centre Chirurgical Marie Lannelongue, Truffle Capital, a leading European venture capital firm, ALIAD (Air Liquides venture capital investor), CorNovum (an investment holding company held 50-50 by Bpifrance and the French State), the family offices of Pierre Bastid (Lohas), of Dr. Antonino Ligresti (Sant Holdings S.R.L.), of the Gaspard family (Corely Belgium SPRL and Bratya SPRL) and of M. Pierre-Edouard Strin (BAD 21 SPRL), Groupe Therabel as well as the thousands of institutional and individual shareholders who have placed their trust in CARMAT.
For more information: http://www.carmatsa.com
Name: CARMAT ISIN code: FR0010907956 Ticker: ALCAR
DISCLAIMER This press release and the information contained herein do not constitute an offer to sell or subscribe to, or a solicitation of an offer to buy or subscribe to, shares in CARMAT ("the Company") in any country. This press release contains forwardlooking statements that relate to the Companys objectives. Such forwardlooking statements are based solely on the current expectations and assumptions of the Companys management and involve risk and uncertainties. Potential risks and uncertainties include, without limitation, whether the Company will be successful in implementing its strategies, whether there will be continued growth in the relevant market and demand for the Companys products, new products or technological developments introduced by competitors, and risks associated with managing growth. The Companys objectives as mentioned in this press release may not be achieved for any of these reasons or due to other risks and uncertainties.
No guarantee can be given as to any of the events anticipated by the forward-looking statements, which are subject to inherent risks, including those described in the Document de Rfrence registration document filed with the Autorit des Marchs Financiers under number D.19-0135 on March 12, 2019, as well as changes in economic conditions, the financial markets or the markets in which CARMAT operates. In particular, no guarantee can be given concerning the Companys ability to finalize the development, validation and industrialization of the prosthesis and the equipment required for its use, to manufacture the prostheses, satisfy the requirements of the ANSM, enroll patients, obtain satisfactory clinical results, perform the clinical trials and tests required for CE marking and to obtain the CE mark. CARMAT products are currently exclusively used within the framework of clinical trials.
Follow this link:
CARMAT Granted Authorization to Resume the PIVOTAL Study in Kazakhstan - Business Wire
- Multicenter Study Evaluates Trend Accuracy of Noninvasive, Continuous Masimo SpHb and Two Invasive Hemoglobin Testing Methods - BioSpace - December 10th, 2019
- Medical society honors Mercy Health - Springfield for its patient care - Springfield News Sun - December 10th, 2019
- Cardiac Surgery Instruments Market Demand and Growth Analysis with Forecast up to 2022 - Techi Labs - December 10th, 2019
- Dexur & researchers from top institutions such as Harvard Medical School collaborate to publish several research papers based on Real World... - December 10th, 2019
- 3D printer could change the way children's heart surgery is performed in Southampton - Daily Echo - December 10th, 2019
- December 2019 Global Surgical Kits Market Demand and Analysis of Key Players, Opportunities and Future Scope Till 2026 - The Chicago Sentinel - December 10th, 2019
- Troubled Childrens Hospital Is Sued Over Toddler Who Died After Surgery - The New York Times - December 7th, 2019
- Duke performs America's first adult heart donation after circulatory death - The Daily Briefing - December 7th, 2019
- CytoSorbents to Present at the Piper Jaffray 31st Annual Healthcare Conference - PRNewswire - December 7th, 2019
- Families reeling after FDA rejects therapy for kids without a thymus - STAT - December 7th, 2019
- Call for hospitals to offer suitable patients a 'minimally invasive' alternative to open heart surgery - Independent.ie - December 7th, 2019
- Cardiac Surgery Instruments Market Is Presumed To Grow At A Strong CAGR Of 6.3% By The End Of 2022 - Drnewsindustry - December 7th, 2019
- Raga therapy: Can music really cure mental and physical ailments? - The Sunday Guardian - December 7th, 2019
- 17-Year-Old With Heart Condition Receives Treatment After NDTV Report - NDTV News - December 7th, 2019
- Global Cardiac Surgical Devices Market : What Will Be The Future Growth Opportunities? - Health News Today - December 7th, 2019
- Easton Hospital is sending more patients to St. Lukes, and maternity care could be next - lehighvalleylive.com - December 2nd, 2019
- Opinion: ER Boarding Is A 'National Crisis' That Needs A Solution : Shots - Health News - NPR - December 2nd, 2019
- Ethiopian kids meet the Israelis who saved their lives - ISRAEL21c - December 2nd, 2019
- Im A Surgeon. Heres What Happened When I Held My Patients Hand And Prayed For Her. - HuffPost - December 2nd, 2019
- Hospital is slammed for care of people with life-threatening conditions - Daily Echo - December 2nd, 2019
- On the move at Free Arts, SVN, Jaburg Wilk, Sundt, PCH - AZ Big Media - December 2nd, 2019
- Larry King Reveals Why He Was In A Coma For Several Weeks Earlier This Year - The Inquisitr - December 2nd, 2019
- Save your heart: Advice from India's top heart surgeon - Stock Daily Dish - December 2nd, 2019
- Global Minimally Invasive Surgery Market Size, Share, Analysis, Applications, Growth Insight, Trends, Key Leaders, Services and 2024 Forecast - Downey... - December 2nd, 2019
- Suspended Animation: Can Cooling Our Bodies To Super Low Temperatures Save Us After Deadly Trauma And Blood Loss? - Forbes - November 28th, 2019
- Heart Surgeon unlawfully suspended from her job at St George's Hospital is reinstated by High Court Judge - London News Online - November 28th, 2019
- Chapel Hill surgery simulation startup KindHeart raises around $569000 in debt - WRAL Tech Wire - November 28th, 2019
- Nuffield Health reaches halfway point in its new build - ITIJ - November 28th, 2019
- Global Cardiac Surgery Devices Market Research: Key Companies Profile with Sales, Revenue, Price and Competitive Situation Analysis - Market Research... - November 28th, 2019
- Cardiac Surgery Devices Market to Witness CAGR of 3.7% Rise in Value Share During the Period 2017 2027 - Statsflash - November 28th, 2019
- Latest R&D and Technological Developments in Heart Valve Replacement - Specialty Medical Dialogues - November 28th, 2019
- Market Insights of Cardiac Surgery Instruments Market by Top Key Players, Size, Drivers & Market Dynamics Forces 2024 - M Herald 24 - November 28th, 2019
- Extracellular Matrix (ECM) Patches Market Dynamic Demand and Drives with Forecast to 2028 - Crypto Journal - November 28th, 2019
- Minimally Invasive Surgery Market Growth Rate, Production Volume and Future Opportunities From 2019-2024 - Correspondent 24 - November 28th, 2019
- Highmark Health's VITAL Innovation Platform is testing the benefits of Moving Analytics' virtual cardiac rehabilitation program - PRNewswire - November 22nd, 2019
- Global Cardiac Surgery Devices Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2025 - Industry News Time 24 - November 22nd, 2019
- Edited Transcript of SSH earnings conference call or presentation 5-Nov-19 2:00pm GMT - Yahoo Finance - November 22nd, 2019
- 2019 Top Doctors in the Philadelphia and Main Line Areas - Mainline Today - November 22nd, 2019
- Phoenix Children's Adds Top Surgeon to its Top-Ranked Heart Center Cardiology2.0 - Cardiology2.0 - November 22nd, 2019
- Appeal to help Wigan couple as their seriously ill baby daughter waits for open heart surgery - Wigan Today - November 22nd, 2019
- Six-year-old Auckland girl ticks snow off wish list as heart surgery awaits - Stuff.co.nz - November 22nd, 2019
- Ronald C. Hill, MD, a Cardiothoracic Surgeon Who is Retired From Practice - The Magazine Plus - November 22nd, 2019
- Global Cardiovascular Needle Market: What it got next? Find out with the latest research available at 'The Market Reports' - Market Research Base - November 22nd, 2019
- Oversupply of Congenital Heart Surgery Programs Slammed - MedPage Today - November 20th, 2019
- UTHealth expert successfully performs surgery on patient with heart problems - News-Medical.net - November 20th, 2019
- Phoenix Children's Adds Top Surgeon to its Top-Ranked Heart Center - PRNewswire - November 20th, 2019
- CARMAT granted authorization to resume the PIVOTAL study in the Czech Republic - Business Wire - November 20th, 2019
- Highmark Health's VITAL Innovation Platform is testing the benefits of Moving Analytics' virtual cardiac rehabilitation program - P&T Community - November 20th, 2019
- Over 60 New Safety Reports Filed With FDA for Maquet IABPs Turning Off During Use - Diagnostic and Interventional Cardiology - November 20th, 2019
- CytoSorbents to Present at the Three Part Advisors 2019 Southwest IDEAS Investor Conference - Yahoo Finance - November 20th, 2019
- What to Know About That Major Study on Stents and Heart Disease - Healthline - November 20th, 2019
- Analysis: With 7000 patients on waiting list Ethiopias Cardiac Center fights to stay open - addisstandard.com - November 20th, 2019
- Synthetic bear bile could improve effectiveness of human heart transplants - The New Economy - November 20th, 2019
- STAT3-miR-17/20 Signaling Axis Plays a Critical Role in Attenuating Myocardial Infarction Following Rapamycin Treatment in Diabetic Mice - DocWire... - November 20th, 2019
- Stents cant take the place of diet and exercise: What Indians should really take away from the ISCHEMIA... - Firstpost - November 20th, 2019
- Patients love easier heart valve replacement operation, but it's not for everyone - AZCentral.com - November 18th, 2019
- Were on the front line: the teens pushing for flavored e-cigarettes ban - The Guardian - November 18th, 2019
- Ramesh Hospitals Vijayawada Sets Guinness World Record for the Largest Gathering of Cardiac Surgery Patients at One Place - Business Wire India - November 18th, 2019
- The enemy called platelets - The News on Sunday - November 18th, 2019
- Stents, bypass surgery show no benefit in heart disease mortality rates among stable patients - Stanford Medical Center Report - November 16th, 2019
- ISCHEMIA Trial Finds No Evidence of Lower Cardiac Event Rates in Patients Treated with Heart Procedures, but Better Quality of Life - Cath Lab Digest - November 16th, 2019
- Global Cardiac Surgery Devices Market by Types, Applications, Countries, Companies and Forecasts to 2024 covered in a Latest Research - Editorials 360 - November 16th, 2019
- This Plastic Surgeon Believes Injectables Are the Future - The Cut - November 15th, 2019
- When it Comes to Frail Patients, There's No Such Thing as Low-Risk Surgery - HealthLeaders Media - November 15th, 2019
- Iraqi baby gets a second chance at life after heart surgery - The Hindu - November 15th, 2019
- Ramesh Hospitals Vijayawada sets Guinness World Record for the largest gathering of cardiac surgery patients at one place - ANI News - November 15th, 2019
- ACC, AHA push for legislation that would expand access to cardiac rehab programs - Cardiovascular Business - November 15th, 2019
- Midland man has much to be thankful for - Midland Daily News - November 15th, 2019
- November 2019, Global Minimally Invasive Surgery Market Segmented by Type, Application and Geography Growth, Trends, and Forecast (2019 2026) -... - November 15th, 2019
- Child genius, 9, to become world's youngest university graduate - New Straits Times - November 15th, 2019
- CHF Solutions Inc (NASDAQ:CHFS) Retains Services Of An Executive Search Firm To Realign Sales Force To Focus On Cardiac Surgery - Journal Transcript - November 15th, 2019
- King of Hearts | Research Horizons - Research Horizons - October 26th, 2019
- Atrial Fibrillation in Adults with Congenital Heart Disease Following Cardiac Surgery in a Single Center: Analysis of Incidence and Risk Factors -... - October 26th, 2019
- Ottawa-based treatment an unprecedented leap forward in addressing damage after heart attack - Ottawa Citizen - October 26th, 2019
- He has undergone 23 heart procedures. But that doesnt stop Old Colony freshman Brady Weglowski from playing the game he loves. - SouthCoastToday.com - October 26th, 2019
- Aarogyasri expanded to hospitals in Bengaluru, Chennai and Hyderabad - The Hindu - October 26th, 2019
- Ottawa-based treatment a leap forward in addressing heart failure - Edmonton Sun - October 26th, 2019
- Doctors, the more the better? | TNS - The News on Sunday - October 26th, 2019
- Cardiac Surgery Instruments Market 2017 2022 in-depth Analysis Globally by Top Leading Players: Delacroix-Chevalier, Cardinal Health Inc., CONMED... - October 26th, 2019
- FDA Affirms Snus as Harm Reduction. Does This Signal Hope for Vaping? - Filter - October 26th, 2019